Clinical Trials in Dallas

Showing 3281-3300 of 17,468 trials

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

NCT03169881

Study Hypothesis: Preterm infants administered weekly Darbe during the neonatal period will have improved neurocognitive outcome at 22-26 months compared to placebo

NeurocognitiveNeuroprotectiveNeonatal+1 more

NICHD Neonatal Research Network650 participantsStarted Sep 2017

Birmingham, Alabama, United States • Palo Alto, California, United States • Atlanta, Georgia, United States +13 more locations

COMPLETEDPhase 2< 1 mile

Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

NCT04880434

The goal of this clinical study is to test how well the study drug, brexucabtagene autoleucel (KTE-X19), works in participants with relapsed/refractory (r/r) mantle cell lymphoma (MCL).

Relapsed/Refractory Mantle Cell Lymphoma

Kite, A Gilead Company95 participantsStarted Apr 2021

Gilbert, Arizona, United States • Palo Alto, California, United States • Santa Monica, California, United States +37 more locations

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

Find Trials by Condition in Dallas

12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

A Study to Assess Growth in Children With Idiopathic Short Stature

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

A Study of PF-06873600 in People With Cancer

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

A Trial Evaluating TG4050 in Ovarian Carcinoma.

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism